Table of Contents

- C M Clark, Jr
How should we respond to the worldwide diabetes epidemic?
Diabetes Care April 1998 21:475-476; doi:10.2337/diacare.21.4.475
- Full Text (PDF)
Select this article
- M J Tikkanen,
- M Laakso,
- M Ilmonen,
- E Helve,
- E Kaarsalo,
- E Kilkki,
- and J Saltevo
Treatment of hypercholesterolemia and combined hyperlipidemia with simvastatin and gemfibrozil in patients with NIDDM. A multicenter comparison study.
Diabetes Care April 1998 21:477-481; doi:10.2337/diacare.21.4.477
- Abstract
- Full Text (PDF)
Select this article
- K Yoshioka,
- M Imanishi,
- Y Konishi,
- T Sato,
- S Tanaka,
- G Kimura,
- and S Fujii
Glomerular charge and size selectivity assessed by changes in salt intake in type 2 diabetic patients.
Diabetes Care April 1998 21:482-486; doi:10.2337/diacare.21.4.482
- Abstract
- Full Text (PDF)
Select this article
- A C Desfaits,
- O Serri,
- and G Renier
Normalization of plasma lipid peroxides, monocyte adhesion, and tumor necrosis factor-alpha production in NIDDM patients after gliclazide treatment.
Diabetes Care April 1998 21:487-493; doi:10.2337/diacare.21.4.487
- Abstract
- Full Text (PDF)
Select this article
- C E Friedberg,
- M J Janssen,
- R J Heine,
- and D E Grobbee
Fish oil and glycemic control in diabetes. A meta-analysis.
Diabetes Care April 1998 21:494-500; doi:10.2337/diacare.21.4.494
- Abstract
- Full Text (PDF)
Select this article
- I M el-Kebbi,
- D C Ziemer,
- D L Gallina,
- and L S Phillips
Diabetes in urban African-Americans. VI. Utility of fasting or random glucose in identifying poor glycemic control.
Diabetes Care April 1998 21:501-505; doi:10.2337/diacare.21.4.501
- Abstract
- Full Text (PDF)
Select this article
- G Yosipovitch,
- E Hodak,
- P Vardi,
- I Shraga,
- M Karp,
- E Sprecher,
- and M David
The prevalence of cutaneous manifestations in IDDM patients and their association with diabetes risk factors and microvascular complications.
Diabetes Care April 1998 21:506-509; doi:10.2337/diacare.21.4.506
- Abstract
- Full Text (PDF)
Select this article
- L Agrawal,
- N V Emanuele,
- C Abraira,
- W G Henderson,
- S R Levin,
- C T Sawin,
- C K Silbert,
- F Q Nuttall,
- J P Comstock,
- and J A Colwell
Ethnic differences in the glycemic response to exogenous insulin treatment in the Veterans Affairs Cooperative Study in Type 2 Diabetes Mellitus (VA CSDM).
Diabetes Care April 1998 21:510-515; doi:10.2337/diacare.21.4.510
- Abstract
- Full Text (PDF)
Select this article
- M Yoshinari,
- M Wakisaka,
- and M Fujishima
Serum leptin levels in smokers with type 2 diabetes.
Diabetes Care April 1998 21:516-517; doi:10.2337/diacare.21.4.516
- Abstract
- Full Text (PDF)
Select this article
- M I Harris,
- K M Flegal,
- C C Cowie,
- M S Eberhardt,
- D E Goldstein,
- R R Little,
- H M Wiedmeyer,
- and D D Byrd-Holt
Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.
Diabetes Care April 1998 21:518-524; doi:10.2337/diacare.21.4.518
- Abstract
- Full Text (PDF)
Select this article
- Z Yang,
- K Wang,
- T Li,
- W Sun,
- Y Li,
- Y F Chang,
- J S Dorman,
- and R E LaPorte
Childhood diabetes in China. Enormous variation by place and ethnic group.
Diabetes Care April 1998 21:525-529; doi:10.2337/diacare.21.4.525
- Abstract
- Full Text (PDF)
Select this article
- J Y Park,
- H K Kim,
- Y E Chung,
- S W Kim,
- S K Hong,
- and K U Lee
Incidence and determinants of microalbuminuria in Koreans with type 2 diabetes.
Diabetes Care April 1998 21:530-534; doi:10.2337/diacare.21.4.530
- Abstract
- Full Text (PDF)
Select this article
- A E Gold,
- R Reilly,
- J Little,
- and J D Walker
The effect of glycemic control in the pre-conception period and early pregnancy on birth weight in women with IDDM.
Diabetes Care April 1998 21:535-538; doi:10.2337/diacare.21.4.535
- Abstract
Select this article
- A M Adlerberth,
- A Rosengren,
- and L Wilhelmsen
Diabetes and long-term risk of mortality from coronary and other causes in middle-aged Swedish men. A general population study.
Diabetes Care April 1998 21:539-545; doi:10.2337/diacare.21.4.539
- Abstract
- Full Text (PDF)
Select this article
- B Berger,
- G Stenström,
- Y F Chang,
- and G Sundkvist
The prevalence of diabetes in a Swedish population of 280,411 inhabitants. A report from the Skaraborg Diabetes Registry.
Diabetes Care April 1998 21:546-548; doi:10.2337/diacare.21.4.546
- Abstract
- Full Text (PDF)
Select this article
- A Grandinetti,
- H K Chang,
- M K Mau,
- J D Curb,
- E K Kinney,
- R Sagum,
- and R F Arakaki
Prevalence of glucose intolerance among Native Hawaiians in two rural communities. Native Hawaiian Health Research (NHHR) Project.
Diabetes Care April 1998 21:549-554; doi:10.2337/diacare.21.4.549
- Abstract
- Full Text (PDF)
Select this article
- S A James,
- L Jamjoum,
- T E Raghunathan,
- D S Strogatz,
- E D Furth,
- and P G Khazanie
Physical activity and NIDDM in African-Americans. The Pitt County Study.
Diabetes Care April 1998 21:555-562; doi:10.2337/diacare.21.4.555
- Abstract
- Full Text (PDF)
Select this article
- S O Ebbesson,
- C D Schraer,
- P M Risica,
- A I Adler,
- L Ebbesson,
- A M Mayer,
- E V Shubnikof,
- J Yeh,
- O T Go,
- and D C Robbins
Diabetes and impaired glucose tolerance in three Alaskan Eskimo populations. The Alaska-Siberia Project.
Diabetes Care April 1998 21:563-569; doi:10.2337/diacare.21.4.563
- Abstract
- Full Text (PDF)
Select this article
- G Schernthaner,
- W Wein,
- K Sandholzer,
- S Equiluz-Bruck,
- P C Bates,
- and M A Birkett
Postprandial insulin lispro. A new therapeutic option for type 1 diabetic patients.
Diabetes Care April 1998 21:570-573; doi:10.2337/diacare.21.4.570
- Abstract
- Full Text (PDF)
Select this article
- C Abraira,
- W G Henderson,
- J A Colwell,
- F Q Nuttall,
- J P Comstock,
- N V Emanuele,
- S R Levin,
- C T Sawin,
- and C K Silbert
Response to intensive therapy steps and to glipizide dose in combination with insulin in type 2 diabetes. VA feasibility study on glycemic control and complications (VA CSDM).
Diabetes Care April 1998 21:574-579; doi:10.2337/diacare.21.4.574
- Abstract
- Full Text (PDF)
Select this article
- A Schindl,
- M Schindl,
- H Schön,
- R Knobler,
- L Havelec,
- and L Schindl
Low-intensity laser irradiation improves skin circulation in patients with diabetic microangiopathy.
Diabetes Care April 1998 21:580-584; doi:10.2337/diacare.21.4.580
- Abstract
- Full Text (PDF)
Select this article
- G A Brunner,
- M Ellmerer,
- G Sendlhofer,
- A Wutte,
- Z Trajanoski,
- L Schaupp,
- F Quehenberger,
- P Wach,
- G J Krejs,
- and T R Pieber
Validation of home blood glucose meters with respect to clinical and analytical approaches.
Diabetes Care April 1998 21:585-590; doi:10.2337/diacare.21.4.585
- Abstract
- Full Text (PDF)
Select this article
- L F Meneghini,
- A M Albisser,
- R B Goldberg,
- and D H Mintz
An electronic case manager for diabetes control.
Diabetes Care April 1998 21:591-596; doi:10.2337/diacare.21.4.591
- Abstract
- Full Text (PDF)
Select this article
- P Tatti,
- M Pahor,
- R P Byington,
- P Di Mauro,
- R Guarisco,
- G Strollo,
- and F Strollo
Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM.
Diabetes Care April 1998 21:597-603; doi:10.2337/diacare.21.4.597
- Abstract
- Full Text (PDF)
Select this article
- H Andersen
Muscular endurance in long-term IDDM patients.
Diabetes Care April 1998 21:604-609; doi:10.2337/diacare.21.4.604
- Abstract
- Full Text (PDF)
Select this article
- J R Erbey,
- L H Kuller,
- D J Becker,
- and T J Orchard
The association between a family history of type 2 diabetes and coronary artery disease in a type 1 diabetes population.
Diabetes Care April 1998 21:610-614; doi:10.2337/diacare.21.4.610
- Abstract
- Full Text (PDF)
Select this article
- K Ohgaki,
- K Nakano,
- H Shigeta,
- Y Kitagawa,
- N Nakamura,
- K Iwamoto,
- M Makino,
- Y Takanashi,
- S Kajiyama,
- and M Kondo
Ratio of motor nerve conduction velocity to F-wave conduction velocity in diabetic neuropathy.
Diabetes Care April 1998 21:615-618; doi:10.2337/diacare.21.4.615
- Abstract
- Full Text (PDF)
Select this article
- T Yamanouchi,
- T Kawasaki,
- T Yoshimura,
- T Inoue,
- E Koshibu,
- N Ogata,
- H Funato,
- I Akaoka,
- and H Miyashita
Relationship between serum 1,5-anhydroglucitol and urinary excretion of N-acetylglucosaminidase and albumin determined at onset of NIDDM with 3-year follow-up.
Diabetes Care April 1998 21:619-624; doi:10.2337/diacare.21.4.619
- Abstract
- Full Text (PDF)
Select this article
- E Faglia,
- F Favales,
- A Quarantiello,
- P Calia,
- P Clelia,
- G Brambilla,
- A Rampoldi,
- and A Morabito
Angiographic evaluation of peripheral arterial occlusive disease and its role as a prognostic determinant for major amputation in diabetic subjects with foot ulcers.
Diabetes Care April 1998 21:625-630; doi:10.2337/diacare.21.4.625
- Abstract
- Full Text (PDF)
Select this article
- D Giugliano,
- R Marfella,
- R Acampora,
- R Giunta,
- L Coppola,
- and F D'Onofrio
Effects of perindopril and carvedilol on endothelium-dependent vascular functions in patients with diabetes and hypertension.
Diabetes Care April 1998 21:631-636; doi:10.2337/diacare.21.4.631
- Abstract
- Full Text (PDF)
Select this article
- T M Davis,
- R W Parsons,
- R J Broadhurst,
- M S Hobbs,
- and K Jamrozik
Arrhythmias and mortality after myocardial infarction in diabetic patients. Relationship to diabetes treatment.
Diabetes Care April 1998 21:637-640; doi:10.2337/diacare.21.4.637
- Abstract
- Full Text (PDF)
Select this article
- R S Elkeles,
- J R Diamond,
- C Poulter,
- S Dhanjil,
- A N Nicolaides,
- S Mahmood,
- W Richmond,
- H Mather,
- P Sharp,
- and M D Feher
Cardiovascular outcomes in type 2 diabetes. A double-blind placebo-controlled study of bezafibrate: the St. Mary's, Ealing, Northwick Park Diabetes Cardiovascular Disease Prevention (SENDCAP) Study.
Diabetes Care April 1998 21:641-648; doi:10.2337/diacare.21.4.641
- Abstract
- Full Text (PDF)
Select this article
- G Imperatore,
- G Riccardi,
- C Iovine,
- A A Rivellese,
- and O Vaccaro
Plasma fibrinogen: a new factor of the metabolic syndrome. A population-based study.
Diabetes Care April 1998 21:649-654; doi:10.2337/diacare.21.4.649
- Abstract
- Full Text (PDF)
- R M Califf and
- C B Granger
Hypertension and diabetes and the Fosinopril versus Amlodipine Cardiovascular Events Trial (FACET). More ammunition against surrogate end points.
Diabetes Care April 1998 21:655-657; doi:10.2337/diacare.21.4.655
- Full Text (PDF)
- Z T Bloomgarden
International Diabetes Federation Meeting, 1997, and Metropolitan Diabetes Society of New York Meeting, November 1997. Approaches to treatment and other topics in type 1 diabetes; genetic heterogeneity of diabetes.
Diabetes Care April 1998 21:658-665; doi:10.2337/diacare.21.4.658
- Full Text (PDF)
- A Ramachandran,
- C Snehalatha,
- E Latha,
- and V Vijay
Evaluation of the use of fasting plasma glucose as a new diagnostic criterion for diabetes in Asian Indian population.
Diabetes Care April 1998 21:666-667; doi:10.2337/diacare.21.4.666
- Full Text (PDF)
- T M Wolever
Assessing the antihyperglycemic effect of acarbose. Solid or liquid test meal?
Diabetes Care April 1998 21:667-668; doi:10.2337/diacare.21.4.667
- Full Text (PDF)
- N J Wareham,
- R Swinn,
- M S Fineman,
- J E Koda,
- K Taylor,
- D E Williams,
- and S O Rahilly
Gestational diabetes mellitus is associated with an increase in the total concentration of amylin molecules.
Diabetes Care April 1998 21:668-669; doi:10.2337/diacare.21.4.668
- Full Text (PDF)
- C Abraira,
- J A Colwell,
- F Nuttall,
- N Emanuele,
- J Comstock,
- S Levin,
- C Sawin,
- and C Silbert
A critical issue. Intensive insulin treatment and macrovascular disease.
Diabetes Care April 1998 21:669-671; doi:10.2337/diacare.21.4.669
- Full Text (PDF)
- R W Holl,
- C Buck,
- H Cario,
- A Wolf,
- A Thon,
- E Kohne,
- and K M Debatin
Diagnosis of diabetes in cystic fibrosis and thalassemia major.
Diabetes Care April 1998 21:671-672; doi:10.2337/diacare.21.4.671
- Full Text (PDF)
- R Hayashi,
- N Hayakawa,
- M Makino,
- M Nagata,
- H Kakizawa,
- K Uchimura,
- M Hamada,
- T Aono,
- T Fujita,
- R Shinohara,
- A Nagasaka,
- and M Itoh
Changes in erythrocyte sorbitol concentrations measured using an improved assay system in patients with diabetic complications and treated with aldose reductase inhibitor.
Diabetes Care April 1998 21:672-673; doi:10.2337/diacare.21.4.672
- Full Text (PDF)
- T W van Haeften
Glucose tolerance, insulin sensitivity, and the homeostasis model assessment method.
Diabetes Care April 1998 21:673-674; doi:10.2337/diacare.21.4.673
- Full Text (PDF)
- R Hitchman,
- G Mathur,
- and A McElduff
Screening for gestational diabetes. What is the no-show rate?
Diabetes Care April 1998 21:674-675; doi:10.2337/diacare.21.4.674
- Full Text (PDF)
- M Fukui,
- N Nakamura,
- K Nakano,
- M Sawada,
- O Aoji,
- H Obayashi,
- H Shigeta,
- and M Kondo
Antibodies to GAD in elderly patients with previously diagnosed NIDDM.
Diabetes Care April 1998 21:675-676; doi:10.2337/diacare.21.4.675
- Full Text (PDF)
- S Amemiya
Constant infused glucose regimen during the recovery phase of diabetic ketoacidosis in children and adolescents with IDDM.
Diabetes Care April 1998 21:676-677; doi:10.2337/diacare.21.4.676
- Full Text (PDF)
- A L Swislocki and
- R Noth
Case report. Pseudohepatotoxicity of metformin.
Diabetes Care April 1998 21:677-678; doi:10.2337/diacare.21.4.677
- Full Text (PDF)

How should we respond to the worldwide diabetes epidemic?

Treatment of hypercholesterolemia and combined hyperlipidemia with simvastatin and gemfibrozil in patients with NIDDM. A multicenter comparison study.

Glomerular charge and size selectivity assessed by changes in salt intake in type 2 diabetic patients.

Normalization of plasma lipid peroxides, monocyte adhesion, and tumor necrosis factor-alpha production in NIDDM patients after gliclazide treatment.

Fish oil and glycemic control in diabetes. A meta-analysis.

Diabetes in urban African-Americans. VI. Utility of fasting or random glucose in identifying poor glycemic control.

The prevalence of cutaneous manifestations in IDDM patients and their association with diabetes risk factors and microvascular complications.

Ethnic differences in the glycemic response to exogenous insulin treatment in the Veterans Affairs Cooperative Study in Type 2 Diabetes Mellitus (VA CSDM).

Serum leptin levels in smokers with type 2 diabetes.

Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.

Childhood diabetes in China. Enormous variation by place and ethnic group.

Incidence and determinants of microalbuminuria in Koreans with type 2 diabetes.

The effect of glycemic control in the pre-conception period and early pregnancy on birth weight in women with IDDM.

Diabetes and long-term risk of mortality from coronary and other causes in middle-aged Swedish men. A general population study.

The prevalence of diabetes in a Swedish population of 280,411 inhabitants. A report from the Skaraborg Diabetes Registry.

Prevalence of glucose intolerance among Native Hawaiians in two rural communities. Native Hawaiian Health Research (NHHR) Project.

Physical activity and NIDDM in African-Americans. The Pitt County Study.

Diabetes and impaired glucose tolerance in three Alaskan Eskimo populations. The Alaska-Siberia Project.

Postprandial insulin lispro. A new therapeutic option for type 1 diabetic patients.

Response to intensive therapy steps and to glipizide dose in combination with insulin in type 2 diabetes. VA feasibility study on glycemic control and complications (VA CSDM).

Low-intensity laser irradiation improves skin circulation in patients with diabetic microangiopathy.

Validation of home blood glucose meters with respect to clinical and analytical approaches.

An electronic case manager for diabetes control.

Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM.

Muscular endurance in long-term IDDM patients.

The association between a family history of type 2 diabetes and coronary artery disease in a type 1 diabetes population.

Ratio of motor nerve conduction velocity to F-wave conduction velocity in diabetic neuropathy.

Relationship between serum 1,5-anhydroglucitol and urinary excretion of N-acetylglucosaminidase and albumin determined at onset of NIDDM with 3-year follow-up.

Angiographic evaluation of peripheral arterial occlusive disease and its role as a prognostic determinant for major amputation in diabetic subjects with foot ulcers.

Effects of perindopril and carvedilol on endothelium-dependent vascular functions in patients with diabetes and hypertension.

Arrhythmias and mortality after myocardial infarction in diabetic patients. Relationship to diabetes treatment.

Cardiovascular outcomes in type 2 diabetes. A double-blind placebo-controlled study of bezafibrate: the St. Mary's, Ealing, Northwick Park Diabetes Cardiovascular Disease Prevention (SENDCAP) Study.

Plasma fibrinogen: a new factor of the metabolic syndrome. A population-based study.

Hypertension and diabetes and the Fosinopril versus Amlodipine Cardiovascular Events Trial (FACET). More ammunition against surrogate end points.

International Diabetes Federation Meeting, 1997, and Metropolitan Diabetes Society of New York Meeting, November 1997. Approaches to treatment and other topics in type 1 diabetes; genetic heterogeneity of diabetes.

Evaluation of the use of fasting plasma glucose as a new diagnostic criterion for diabetes in Asian Indian population.

Assessing the antihyperglycemic effect of acarbose. Solid or liquid test meal?

Gestational diabetes mellitus is associated with an increase in the total concentration of amylin molecules.

A critical issue. Intensive insulin treatment and macrovascular disease.

Diagnosis of diabetes in cystic fibrosis and thalassemia major.

Changes in erythrocyte sorbitol concentrations measured using an improved assay system in patients with diabetic complications and treated with aldose reductase inhibitor.

Glucose tolerance, insulin sensitivity, and the homeostasis model assessment method.

Screening for gestational diabetes. What is the no-show rate?

Antibodies to GAD in elderly patients with previously diagnosed NIDDM.

Constant infused glucose regimen during the recovery phase of diabetic ketoacidosis in children and adolescents with IDDM.

Case report. Pseudohepatotoxicity of metformin.

This Issue

Current Issue

From the Cover